Maryland vs New Jersey
Side-by-side analysis of Maryland and New Jersey for cannabis business strategy, with a decisive recommendation from Hoban Law Group.
Side-by-Side Comparison
| Factor | Maryland | New Jersey | Verdict |
|---|---|---|---|
| Adult-use launch | Adult-use since July 2023 | Adult-use since April 2022 | New Jersey wins New Jersey has a one-year operational head start, giving New Jersey operators more experience with adult-use compliance and consumer demand patterns. |
| License structure | Conversion of medical licenses + new application rounds | CRC licensing process — merit review + social equity tracks | Neutral Both states have complex multi-track licensing processes with social equity provisions and conversion pathways for existing medical operators. |
| Tax rate | 9% adult-use excise + 6% state sales (15-22% effective) | Graduated by potency + 6.625% state sales (25-35% effective) | Maryland wins Maryland's flat 9% excise and lower state sales tax produce a meaningfully lower effective tax burden than New Jersey's graduated potency-based system. |
| Market size | ~6 million residents — strong DC metro spillover | ~9 million residents — NYC metro spillover | New Jersey wins New Jersey's proximity to New York City and its 9 million resident population produce a larger total addressable market than Maryland. |
| Washington DC proximity | Major advantage — Maryland captures DC-area demand | No equivalent federal district demand anchor | Maryland wins Maryland's proximity to Washington DC — which has a unique cannabis gifting market and 700,000+ residents — creates cannabis demand dynamics that New Jersey does not have. |
| Regulatory consistency | Cannabis Administration — newly operational | CRC — more established with multi-year adult-use experience | New Jersey wins New Jersey's CRC has more adult-use regulatory experience than Maryland's Cannabis Administration, which is still developing its guidance body. |
Maryland vs New Jersey: Mid-Atlantic Cannabis Market Comparison
Maryland and New Jersey are both active Mid-Atlantic adult-use cannabis markets with large populations and proximity to major metropolitan areas. Maryland's tax advantage and Washington DC proximity give it unique demand characteristics; New Jersey's larger population and established CRC framework give it market maturity.
Maryland's Tax Advantage and DC Proximity
Maryland launched adult-use sales in July 2023, and the state has two meaningful competitive advantages relative to New Jersey. First, Maryland's cannabis excise tax of 9% is significantly lower than New Jersey's graduated potency-based system that can reach 20%+ for high-potency products. Second, Maryland's proximity to Washington DC creates cannabis demand dynamics unique in any US market.
Washington DC has passed Initiative 71 and operates a unique "gifting" cannabis economy alongside an emerging licensed medical market. The lack of a full retail adult-use market in DC has driven significant consumer purchasing from Maryland dispensaries near the DC border. Maryland dispensaries in Prince George's County and Montgomery County capture this demand.
New Jersey: The Established Mid-Atlantic Market
New Jersey opened adult-use sales in April 2022, giving it a full year of operational experience over Maryland. The state's Cannabis Regulatory Commission has processed hundreds of adult-use licenses and has established a track record of regulatory decisions that provides guidance for prospective licensees.
New Jersey's 9 million residents and proximity to New York City — which was slower to launch adult-use sales — made New Jersey an early beneficiary of NYC-area consumer demand. As New York's adult-use market has scaled, some of that cross-border demand has been replaced by local New York alternatives, but New Jersey's established operations maintain a home market advantage.
Decision framework
Which fits your business?
Which market fits your business? Maryland is the right choice for operators who want access to DC-metro demand, benefit from Maryland's lower tax rate, and are entering at a time when the Maryland market is still maturing and first-mover advantages remain available. New Jersey is the better choice for operators who want an established regulatory framework, a larger resident population base, and more regulatory precedent to guide compliance strategy — though the higher effective tax rate is a meaningful ongoing cost. For operators entering the Mid-Atlantic for the first time, Maryland's lower taxes and proximity to DC create a compelling near-term opportunity. [Schedule a consultation](/consultation?source=compare&compare=maryland-vs-new-jersey&matter_type=licensing).
Frequently Asked Questions
- How does Washington DC's cannabis market affect Maryland dispensaries?
- Washington DC operates under Initiative 71, which permits cannabis gifting and possession but not commercial adult-use retail sales (federal property restrictions prevent a conventional retail market). This has created significant demand at Maryland dispensaries near the DC border, as DC residents cross state lines to purchase cannabis legally.
- What are Maryland's cannabis tax rates for adult-use?
- Maryland imposes a 9% adult-use excise tax on cannabis sales, plus the state's 6% general sales tax. Combined effective rates are typically 15-22% at retail, depending on local add-on taxes, making Maryland one of the lower-tax adult-use states.
- Is New Jersey still worth entering given that New York's adult-use market has scaled?
- Yes. New Jersey's market is established, its per-door economics in premium locations remain strong, and the state has a large local population base independent of cross-border demand from New York consumers.
- What types of cannabis licenses are available in Maryland and New Jersey?
- Both states issue licenses across multiple tiers: cultivation/grower, processor/manufacturer, dispensary/retailer, and in some cases microbusiness and social equity categories. Both states have active social equity licensing programs.
Related Resources
Work with Hoban Law Group
Get counsel on your Maryland or New Jersey matter
Our team prepares a regulatory briefing specific to your matter before you speak with counsel. No cost. No commitment.
Schedule a consultation